OVERVIEW

Chlamydia and Gonorrhea: The Most Common Treatable STIs is organized by Omnia Education.

Released: 03/13/2018
Valid until: 09/15/2020

Accreditation:
Global Learning Collaborative designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™.

Overview:
Screening, early diagnosis and management are of the utmost importance to reduce the risk of Chlamydia and gonorrhea infections- associated morbidity. In this article, we will review epidemiology and risk factors for Chlamydia and gonorrhea infections, and strategies for screening and diagnosing, including the key role of Nucleic-Acid Amplifications Tests (NAAT). Finally, we will discuss treatment strategies for the patient and sex partner.

Learning Objectives:
After participating in this educational activity, participants should be better able to:

• Summarize current CDC STI diagnosis and treatment guidelines for Chlamydia trachomatis and Neisseria gonorrhea Infections
• Describe the burden of disease and epidemiology of Chlamydia trachomatis and Neisseria gonorrhea STIs in the United States
• Plan appropriate testing that will facilitate the earlier screening and diagnosis of Chlamydia trachomatis and Neisseria gonorrhea infections

Additional details will be posted as soon as information is available.